Patterns of clinical use of antipsychotics in hospitalized psychiatric patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 6, 2005, Pages 957-963

  Mauri, Massimo C ^a   Regispani, Francesca ^a   Beraldo, Scilla ^a   Volonteri, Lucia S ^a   Ferrari, Veronica M ^a   Fiorentini, Alessio ^a   Invernizzi, Giordano ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Atypical antipsychotics; Classical neuroleptics; Clinical practice; Hospitalized patients; Prescription patterns

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOTIAPINE; CLOZAPINE; GABAPENTIN; HALOPERIDOL; HALOPERIDOL DECANOATE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PROMAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; VALPROIC ACID; ZUCLOPENTHIXOL;

ADULT; ANAMNESIS; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; EATING DISORDER; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; MEDICAL RECORD; MENTAL DEFICIENCY; MENTAL HOSPITAL; MENTAL PATIENT; MOOD DISORDER; NEUROSIS; PERSONALITY DISORDER; PSYCHOSIS; SCHIZOPHRENIA;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; SEX FACTORS; TIME FACTORS;

EID: 23144459146     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.06.009     Document Type: Article

References (33)

1. D.B. Allison, J.L. Mentore, M. Heo, P. Weiden, J. Cappellieri, and L.P. Chandler Weight gain associated with conventional and newer antipsychotics: a meta-analysis Eur. Neuropsychopharmacol. 8 Suppl. 2 1998 S216
2. American Psychiatric Association Practice guideline for the treatment of patient with schizophrenia Am. J. Psychiatry 154 Suppl. 4 1997 S1 S63
3. American Psychiatric Association Practice guideline for treatment of patients with schizophrenia, 2nd ed. Am. J. Psychiatry 161 Suppl. 2 2004 S12 S15
4. R.J. Baldessarini, and F.I. Tarazi Drugs and the treatment of psychiatric disorders: antipsychotic and antimanic agents J.G. Hardman L.E. Limbirid A. Goodman Gilman The Pharmacological Basis of Therapeutics 2000 McGraw Hill New York 485 520
5. I. Bitter, J.C. Chou, G.S. Ungvari, W.K. Tang, Z. Xiang, A. Iwanami, and P. Gaszner Prescribing for Inpatients with Schizophrenia: an International Multi-Center Comparative Study Pharmacopsychiatry 36 4 2003 143 149
6. P.F. Buckley, D.D. Miller, B. Singer, and K. Donenwirth The evolving clinical profile of atypical antipsychotic medications Can. J. Psychiatry 46 3 2001 285
7. F. Centorrino, M. Eakin, W.M. Bahk, J.P. Kellehr, J. Goren, P. Salvatore, S. Egli, and R.J. Baldessarini In-patient antipsychotic drug use in 1998, 1993, and 1989 Am. J. Psychiatry 159 11 2002 1932 1935
8. F. Centorrino, J.L. Goren, J. Hennen, P. Salvatore, J.P. Kelleher, and R.J. Baldessarini Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study for risks versus benefits Am. J. Psychiatry 161 2004 700 706
9. L. Ereshefsky Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic J. Clin. Psychiatry 60 Suppl. 10 1999 S20 S30
10. A. Fourrier, I. Gasquet, and M.P. Allicar Patterns of neuroleptic drug prescription: a national cross-sectional survey of a random sample of French psychiatrists J. Clin. Pharmacol. 49 1999 80 86
11. O. Freudenreich, and D.C. Goff Antipsychotic combination therapy in schizophrenia. A review of efficacy and risks of current combinations Acta Psychiatr. Scand. 106 2002 323 330
12. J. Geddes, N. Freemantle, P. Harrison, and P. Bebbington Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis Br. Med. J. 321 2000 1371 1376
13. I.D. Glick, S.R. Murray, P. Vasudevan, S.R. Marder, and R.J. Hu Treatment with atypical antipsychotics: new indications and new populations J. Psychiatr. Res. 35 2001 187 191
14. R. Grohmann, R.R. Engel, K.H. Geisser, and E. Rüther Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study Pharmacopsychiatry 37 Suppl. 1 2004 S27 S38
15. T.J. Hudson, G. Sullivan, W. Feng, R.R. Owen, and C.R. Thrush Economic evaluations of novel antipsychotic medications: a literature review Schizophr. Res. 60 2003 199 218
16. J.A. Kane, D. Carpenter, and J.P. Docherty The Expert Consensus Guideline Series: Optimizing pharmachologic treatment of psychotic disorders J. Clin. Psychiatry 64 Suppl. 12 2003 S1 S100
17. N.A. Keks, K. Altson, J. Hope, N. Krapivensky, C. Cuhne, A. Tanaghow, P. Doherty, and A. Bootle Use of antipsychotics and adjunctive medications by an inner urban community psychiatric service Aust. N. Z. J. Psychiatry 33 1999 896 901
18. B. Lachaux, H. Sontag, F. Casadebaig, A. Philippe, F. Rouillon, P. Clery-Melin, T. Hergueta, P.M. Liorca, T. Moreaudefarges, P. Guillon, and T. Lebrun Pharmacoepidemiological study on antipsychotic drug prescription in French psychiatry: patient characteristics, antipsychotic treatment, and care management for schizophrenia Encephale 28 2002 129 138
19. T.J.R. Lambert, and D.J. Castle Pharmacological approaches to the management of schizophrenia Schizophrenia 178 2003 57 61
20. S. Leucht, G. Pitschel-Walz, D. Abraham, and W. Kissling Efficacy and extrapyramidal side effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomised controlled trials Schizophr. Res. 35 1999 51 68
21. D.L. Leslie, and R.A. Roseneheck From conventional to atypical antipsychotics and back: dynamic process in the diffusion of new medications Am. J. Psychiatry 159 2002 1534 1540
22. J.A. Lieberman Atypical antipsychotic drugs as first-line treatment of schizophrenia: a rationale and hypothesis J. Clin. Psychiatry 57 Suppl. 11 1996 S68 S71
23. J.A. Lieberman, R. Golden, S. Stroup, and J. McEvoy Drugs of the psychopharmacological revolution in clinical psychiatry Psychiatr. Serv. 51 2000 1254 1258
24. C.B. Martin, L.S. Miller, and J.A. Kotzan Antipsychotic prescription use and costs for persons with schizophrenia in the 1990s: current trends and five year time series forecast Schizophr. Res. 47 2001 281 292
25. J.S. McCombs, M.B. Nichol, B.M. Johnstone, J. Shi, and R. Smith Antipsychotic drug use patterns and the cost of treating schizophrenia Psychiatr. Serv. 51 2000 525 527
26. J.P. McEvoy, P.L. Scheifler, and A. Frances The Expert Consensus Guideline Series: Treatment of schizophrenia J. Clin. Psychiatry 60 Suppl. 11 1999 3 80
27. H.Y. Meltzer, and A.E. Kostaoglu Combining antipsychotics: is there evidence for efficacy? Psychiatr. Times 17 Suppl. 9 2000 S25 S34
28. H.J. Moller Novel antipsychotics and negative symptoms Int. Clin. Psychopharmacol. 13 Suppl. 3 1998 S43 S47
29. R.M. Procyshyn, and B. Thompson Patterns of antipsychotic utilization in a tertiary care psychiatric institution Pharmacopsychiatry 37 2004 12 17
30. H. Rittmannsberger, U. Meise, and K. Schauflinger Polypharmacy in psychiatric treatment: patterns of psychotropic drug use in Austrian psychiatric clinics Eur. Psychiatry 14 1999 33 40
31. S.M. Stahl Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials J. Clin. Psychiatry 60 Suppl. 10 1999 S31 S39
32. A. Tapp, A.E. Wood, L. Secrest, J. Erdmann, L. Cubberley, and N. Kilzieh Combination antipsychotic therapy in clinical practice Psychiatr. Serv. 54 2003 55 59
33. D.A. Wirshing, B.J. Spellberg, and S.M. Erhart Novel antipsychotics and new onset diabetes Biol. Psychiatry 44 1998 778 783